Citations

Showing 10 of 108094 citations.

Design and Implementation of an Interactive Website for Pediatric Voice Therapy—The Concept of In-Between Care: A Telehealth Model
Doarn, Charles R. , Zacharias, Stephanie R. C. , Keck, Casey , deAlarcón, Alessandro, Kelchner, Lisa , Zacharias, Stephanie, Tabangin, Meredith E.

Mayo Clinic

Telemedicine and e-Health | June 5, 2018 | Volume: 25 | Issue: 5 | Pages: 415-422

10.1089/tmj.2018.0108 | PMID 29870314 Get It

Purpose: This article describes the design and implementation of a web-based portal developed to provide supported home practice between weekly voice therapy sessions delivered through telehealth to children with voice disorders. This in-between care consisted of supported home practice that was remotely monitored by speech-language pathologists (SLPs). Methods: A web-based voice therapy portal (VTP) was developed as a platform so participants could complete voice therapy home practice by an interdisciplinary team of SLPs (specialized in pediatric voice therapy), telehealth specialists, biomedical informaticians, and interface designers. The VTP was subsequently field tested in a group of children with voice disorders, participating in a larger telehealth study. Results: Building the VTP for supported home practice for pediatric voice therapy was challenging, but successful. Key interactive features of the final site included 11 vocal hygiene questions, traditional voice therapy exercises grouped into levels, audio/visual voice therapy demonstrations, a store-and-retrieval system for voice samples, message/chat function, written guidelines for weekly therapy exercises, and questionnaires for parents to complete after each therapy session. Ten participants (9–14 years of age) diagnosed with a voice disorder were enrolled for eight weekly telehealth voice therapy sessions with follow-up in-between care provided using the VTP. Conclusion: The development and implementation of the VTP as a novel platform for the delivery of voice therapy home practice sessions were effective. We found that a versatile individual, who can work with all project staff (speak the language of both SLPs and information technologists), is essential to the development process. Once the website was established, participants and SLPs effectively utilized the web-based VTP. They found it feasible and useful for needed in-between care and reinforcement of therapeutic exercises.
Ethnic, Geographic, and Genetic Differences in Arsenic Metabolism at Low Arsenic Exposure: A Preliminary Analysis in the Multi-Ethnic Study of Atherosclerosis (MESA)
Balakrishnan, Poojitha , Jones, Miranda R. , Téllez-Plaza, María , Kaufman, Joel D. , Bielinski, Suzette J. , Goessler, Walter , Goessler, Walter , Bielinski, Suzette , Kaufman, Joel D , Vaidya, Dhananjay , Post, Wendy S. , Taylor, Kent D. , Francesconi, Kevin A. , Navas‐Acién, Ana , Jones, Miranda R

Mayo Clinic

International Journal of Environmental Research and Public Health | June 5, 2018 | Volume: 15 | Issue: 6 | Pages: 1179

10.3390/ijerph15061179 | PMID 29874848 Get It

We investigated the effect of candidate variants in AS3MT (arsenic (III) methyltransferase) with urinary arsenic metabolites and their principal components in a subset of 264 participants in the Multi-Ethnic Study of Atherosclerosis (MESA). Urinary arsenic species, including inorganic arsenic (iAs), monomethylarsonate (MMA), dimethylarsinate (DMA), and arsenobetaine (Ab), were measured using high performance liquid chromatography-inductively coupled plasma mass spectrometry (HPLC-ICPMS) and corrected for organic sources from seafood consumption by regressing Ab on arsenic species using a validated method. Principal components of arsenic metabolism were also used as independent phenotypes. We conducted linear regression of arsenic traits with allelic dosage of candidate single nucleotide polymorphisms (SNPs) rs12768205 (G > A), rs3740394 (A > G), and rs3740393 (G > C) measured using Illumina MetaboChip. Models were stratified by non-Hispanic white vs. all other race/ethnicity and adjusted for age, sex, arsenic exposure, study site, and population stratification. Consistent with previous studies, rs12768205 showed evidence for strongest association (non-Hispanic white: iAs% −0.14 (P 0.83), MMA% −0.66 (0.49), DMA% 0.81(0.49); other race/ethnicity: 0.13 (0.71), −1.21 (0.09), 1.08 (0.20)). No association, however, passed the strict Bonferroni p-value. This was a novel study among an ethnically diverse population exposed to low arsenic levels.
Aldoxorubicin Therapy for the Treatment of Patients with Advanced Soft Tissue Sarcoma
Seetharam, ­Mahesh , Kolla, Kantha R. , Ganjoo, Kristen N.

Mayo Clinic

Future Oncology | June 5, 2018 | Volume: 14 | Issue: 23 | Pages: 2323-2333

10.2217/fon-2018-0047 | PMID 29869517 Get It

Updates on Selected Topics in Lung Cancers: Air Space Invasion in Adenocarcinoma and Ki-67 Staining in Carcinoid Tumors
Yi, Eunhee S. , Lee, Geon Kook

Mayo Clinic

Archives of Pathology & Laboratory Medicine | June 5, 2018 | Volume: 142 | Issue: 8 | Pages: 947-951

10.5858/arpa.2017-0482-ra | PMID 29869902 Get It

Context.— Air space invasion or aerogenous spread of lung adenocarcinoma is a relatively new concept and has been implicated as a potential prognostic factor as well as has been added as an exclusion point in the diagnosis of minimally invasive adenocarcinoma. Potential role for Ki-67 immunostaining as a diagnostic and prognostic marker in pulmonary carcinoid tumors has been suggested in the literature, given the significant interobserver variability and the difficulty in predicting their clinical behavior. Objective.— To review the concept of air space invasion in lung adenocarcinoma and the current controversies regarding the role of Ki-67 immunostaining on pulmonary carcinoid tumors Data Sources.— PubMed search of English literature. Conclusions.— Pathologists need to recognize air space invasion with a critical evaluation to differentiate it from artifacts that are commonly seen in sections. Currently, Ki-67 immunostaining is not recommended for routine use in the diagnosis of pulmonary carcinoid tumors or for predicting their prognosis, except for the differential diagnosis from small cell carcinomas or large cell neuroendocrine carcinomas in small biopsy specimens with crush artifacts.
Stress and Achievement of Cardiovascular Health Metrics: The American Heart Association Life's Simple 7 in Blacks of the Jackson Heart Study
Slusser, Joshua P. , Chamberlain, Alanna M. , Roger, Véronique L. , Sims, Mario , Brewer, LaPrincess C. , Patten, Christi A. , Chamberlain, Alanna M , Redmond, Nicole , Scott, Christopher G. , Djoussé, Luc

Mayo Clinic

Journal of the American Heart Association | June 5, 2018 | Volume: 7 | Issue: 11 | Pages: No page available

10.1161/jaha.118.008855 | PMID 29871857 Get It

Background Ideal cardiovascular health metrics (defined by the American Heart Association Life's Simple 7 [LS7]) are suboptimal among blacks, which results in high risk of cardiovascular disease. We examined the association of multiple stressors with LS7 components among blacks. Methods and Results Using a community‐based cohort of blacks (N=4383), we examined associations of chronic stress, minor stressors, major life events, and a cumulative stress score with LS7 components (smoking, diet, physical activity, body mass index, blood pressure, total cholesterol, and fasting plasma glucose) and an LS7 composite score. Multivariable logistic regression assessed the odds of achieving intermediate/ideal levels of cardiovascular health adjusted for demographic, socioeconomic, behavioral, and biomedical factors. The LS7 components with the lowest percentages of intermediate/ideal cardiovascular health levels were diet (39%), body mass index (47%), and physical activity (51%). Higher chronic, minor, and cumulative stress scores were associated with decreased odds (odds ratio [OR]) of achieving intermediate/ideal levels for smoking (OR [95% confidence interval], 0.80 [0.73–0.88], 0.84 [0.75–0.94], and 0.81 [0.74–0.90], respectively). Participants with more major life events had decreased odds of achieving intermediate/ideal levels for smoking (OR, 0.84; 95% confidence interval, 0.76–0.92) and fasting plasma glucose (OR, 0.90; 95% confidence interval, 0.82–0.98). Those with higher scores for minor stressors and major life events were less likely to achieve intermediate or ideal LS7 composite scores (OR [95% confidence interval], 0.89 [0.81–0.97] and 0.91 [0.84–0.98], respectively). Conclusions Blacks with higher levels of multiple stress measures are less likely to achieve intermediate or ideal levels of overall cardiovascular health (LS7 composite score), specific behaviors (smoking), and biological factors (fasting plasma glucose).
Optimal anesthetic strategy for endovascular stroke therapy
Kallmes, David F. , Rabinstein, Alejandro A.

Mayo Clinic

Neurology | June 5, 2018 | Volume: 91 | Issue: 1 | Pages: 16-18

10.1212/wnl.0000000000005754 | PMID 29858470 Get It

The Challenges of Gastroparesis: Changing Study Design to Improve Clinical Care
Lacy, Brian E. , Camilleri, Michael , Lacy, Brian E. , Crowell, Michael D.

Mayo Clinic

American Journal of Gastroenterology | June 5, 2018 | Volume: 114 | Issue: 1 | Pages: 1-3

10.1038/s41395-018-0134-4 | PMID 29875453 Get It

Gene Therapy for Osteoarthritis: Pharmacokinetics of Intra-Articular Self-Complementary Adeno-Associated Virus Interleukin-1 Receptor Antagonist Delivery in an Equine Model
Levings, Rachael S. Watson, Broome, Ted A., Rice, Brett L., Gibbs, Eric P., Myara, David A., Hyddmark, E. Viktoria, Zarezadeh, Ali , Levings, Padraic P., Lu, Yuan , White, Margaret , Dacanay, E. Anthony, Foremny, Gregory B., Evans, Christopher H. , Morton, Alison J. , Winter, Mathew, Dark, Michael J. , Nickerson, David M., Colahan, Patrick T., Ghivizzani, Steven C. , Smith, Andrew D. , Nasri, Elham , Foremny, Gregory B.

Mayo Clinic

Human Gene Therapy Clinical Development | June 5, 2018 | Volume: 29 | Issue: 2 | Pages: 90-100

10.1089/humc.2017.142 | PMID 29869540 Get It

Self-Complementary Adeno-Associated Virus–Mediated Interleukin-1 Receptor Antagonist Gene Delivery for the Treatment of Osteoarthritis: Test of Efficacy in an Equine Model
Levings, Rachael S. Watson, Broome, Ted A., Rice, Brett L., Gibbs, Eric P., Myara, David A., Hyddmark, E. Viktoria, Zarezadeh, Ali , Levings, Padraic P., Lu, Yuan , White, Margaret , Dacanay, E. Anthony, Foremny, Gregory B., Evans, Christopher H. , Morton, Alison J. , Winter, Mathew, Dark, Michael J. , Nickerson, David M., Colahan, Patrick T., Ghivizzani, Steven C. , Smith, Andrew D. , Nasri, Elham , Foremny, Gregory B.

Mayo Clinic

Human Gene Therapy Clinical Development | June 5, 2018 | Volume: 29 | Issue: 2 | Pages: 101-112

10.1089/humc.2017.143 | PMID 29869535 Get It

Ethics and the Legalization of Physician-Assisted Suicide
Sulmasy, Lois Snyder , Mueller, Paul S.

Mayo Clinic

Annals of Internal Medicine | June 4, 2018 | Volume: 168 | Issue: 11 | Pages: 834-835

10.7326/l18-0083 | PMID 29868812 Get It